[Tumor suppressor p53 gene: a potential target for cancer therapy?].
Soussi
T
T
UMR 218 du CNRS, Institut Curie, Paris, France.
D017501:Adenovirus E1B Proteins / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D002455:Cell Division / Q000235:genetics; D004249:DNA Damage; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy
D017501:Adenovirus E1B Proteins; D000970:Antineoplastic Agents